CAR T therapy has seen great effectiveness in liquid tumors, but little in solid tumors (e.g. ovarian cancer).
Here we developed hyper-migratory CAR TV cells to infiltrate en masse ovarian tumors. (Left: control CAR T cells; right CAR TV cells).
Read this here: www.biorxiv.org/content/10.1...
05.10.2025 16:48 — 👍 20 🔁 5 💬 1 📌 0
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Nature - Cancer evolutionary dynamics are quantitatively inferred using a method, EVOFLUx, applied to fluctuating DNA methylation.
Cancer is an evolutionary disease, but does knowing a cancer’s evolutionary past help predict its future? Out today in @nature, we learnt the evolution of 2000 lymphoid cancers and found it was highly correlated with clinical outcomes! (1/7)
rdcu.be/eFrrc
10.09.2025 16:17 — 👍 46 🔁 19 💬 1 📌 2
Fluctuating DNA methylation tracks cancer evolution at clinical scale - Nature
Cancer evolutionary dynamics are quantitatively inferred using a method, EVOFLUx, applied to fluctuating DNA methylation.
Studying cancer evolution needs multi-region or single cell seq for phylogenetics, right? Amazingly (I think!) we found single-sample bulk methylation suffices, via analysis of "fluctuating methylation". In @nature.com today led by brilliant @calumgabbutt.bsky.social www.nature.com/articles/s41...
10.09.2025 15:21 — 👍 92 🔁 39 💬 7 📌 2
Communication in pathology, the power of word. Excellent keynote at #ecp2025 in #vienna!
07.09.2025 10:29 — 👍 2 🔁 0 💬 0 📌 0
So accurate, it hurts
22.08.2025 15:15 — 👍 4 🔁 1 💬 0 📌 0
😂
05.08.2025 17:58 — 👍 0 🔁 0 💬 0 📌 0
Fantastic workshop on the ecology and #evolution of cancer #EBEC2025! So thrilled and proud to have been part of it! @sangerinstitute.bsky.social #cambridge
04.07.2025 12:48 — 👍 5 🔁 0 💬 1 📌 0
Looking forward to the "Evolutionary Biology and Ecology of Cancer" course in #Cambridge at the #wellcome genome campus! #genomics
30.06.2025 10:22 — 👍 3 🔁 0 💬 0 📌 0
#pathsky
Excellent talk on pancreatic neuroendocrine neoplasms at the Spring Meeting of the Austrian Society for Pathology y Konstantin Bräutigam @pathologop.bsky.social #oegpath
15.03.2025 09:59 — 👍 10 🔁 2 💬 1 📌 0
Thank you for inviting! Great meeting!
15.03.2025 11:57 — 👍 1 🔁 0 💬 0 📌 0
The tumour histopathology “glossary” for AI developers
The applications of artificial intelligence (AI) and deep learning (DL) are leading to significant advances in cancer research, particularly in analysing histopathology images for prognostic and treat...
Are you using #AI to analyse #Histopathology images?
A team of ICR researchers have created a glossary to help AI developers understand tumour histopathology.
They hope that this will speed up the development of AI algorithms for cancer research ⤵️
doi.org/10.1371/jour...
28.01.2025 12:54 — 👍 7 🔁 3 💬 1 📌 0
Thanks for sharing ❤️
30.01.2025 08:25 — 👍 0 🔁 0 💬 0 📌 0
Meeting Darth Vader at the #festivalofgenomics! #genomics #excel #london
29.01.2025 12:37 — 👍 2 🔁 0 💬 0 📌 0
Thanks @trevorgraham.bsky.social ! We hope to fill this gap and to boost #cancer research! #ai #pathology
23.01.2025 19:24 — 👍 0 🔁 0 💬 0 📌 0
Tumor infiltrating lymphocytes (TILs) – Pathologia, quo vadis? – A global survey
Tumor-infiltrating lymphocytes (TILs) and the tumor microenvironment have become increasingly important in cancer research, and immunotherapy has achi…
Our survey on routine #TIL reporting has finally been published open access in "Pathology-Research and Practice"!
www.sciencedirect.com/science/arti...
Many thanks to the 77 participants from all over the world, we are grateful for your participation! #pathology #tme #oncology
19.12.2024 07:48 — 👍 2 🔁 1 💬 0 📌 0
Traveling in time to my alma mater, Charité Berlin.
14.12.2024 10:47 — 👍 0 🔁 0 💬 0 📌 0
Inaugural Meeting of the European Society for #Spatial #Biology in Berlin! Lovely venue and excellent line-up! #essb
12.12.2024 08:42 — 👍 6 🔁 0 💬 0 📌 0
Assistant Professor, Cold Spring Harbor Laboratory
Systems immunology to understand thymus physiology and T cell development
@RingAScientist, @SkypeScientist
International research group (Berlin & Houston) led by @dlwagner.bsky.social
CAR-T cells | Non-viral genome engineering | CRISPR | Precision editing | Large knock-ins | Integrases |
Senior Editor @Nature for cancer and cell cycle. Views my own
Population & Human Genetics
Based in the Department of Oncology at the MRC WIMM, University of Oxford | We study the genetics of immunity with a focus on the determinants of response to cancer immunotherapy.
Genetics, immunology, oncology, science.
Associate Dean for Undergraduate Education at Indiana University School of Informatics, Computing and Engineering • mathematical biologist • multicellular systems & cancer with PhysiCell • OpenSource • astrophotography
Web: http://MathCancer.org
Epigenetic Inheritance, Neuroscience & anything biology-related
https://www.odedrechavilab.com/
TED: https://shorturl.at/myFTY
Huberman Lab Podcast: https://youtu.be/CDUetQMKM6g
PhD student in the Jonkers lab |📍Netherlands Cancer Institute | exploring DNA repair mechanisms and therapy resistance 🧬💊
Postdoctoral Training Fellow
Functional Tumour Immunology Lab - Institute of Cancer Research, London
Former PhD student at Institut Cochin, Paris
Melanoma oncologist at The Christie. Wellcome early career fellow at University of Manchester, The Francis Crick and UCL. Interested in tumour local and systemic immune changes, metastasis, ctdna and cancer evolution. Music, art, politics, hiking.
Professor of Cancer Evolution. UCL Cancer Institute. Interested in cancer genomics, bioinformatics, and somatic evolution.
https://www.ucl.ac.uk/medical-sciences/divisions/cancer/our-research/cancer-genome-evolution
Genomics, bioinformatics; attempting to say useful things about cancer and evolution.
Institute of Genetics and Cancer, University of Edinburgh
https://institute-genetics-cancer.ed.ac.uk
https://semplelab.com
Graduate student at Penn with an interest in machine learning
Professor at ASU studying the evolution of cancer. NB: I generated the image in my profile using Midjourney.
aka motoscientist. Lead of the Breast epigenetic plasticity and evolution at ICR. ER+ Breast Cancer all things considered. Old school midfielder. Early adopter of obsolete technologies. Views are my own. ORCID 0000-0002-7534-0785
Scientist. Group leader at the Sanger Institute, Cambridge UK. Somatic mutation and selection in normal tissues, cancer and ageing.
We develop diverse computational approaches to study tumour organisation and dynamics at the Cancer Research UK Scotland Institute @cruk-si.bsky.social
Senior Staff Scientist @sangerinstitute.
Passionate about cancer genetics, functional genomics and precision medicine. Husband of one. Daddy of two.
VP for Research, T.H. Smoot Professor
Depts Chemical and Biomolecular Engn, Pathology, Oncology, INBT
Johns Hopkins University
3D multi-omic, CAR T therapy, cell migration and mechanics
Lab: https://wirtzlab.johnshopkins.edu